Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
latest_posts
- 1
Nine in 10 German industrial firms expect Iran war to hit business - 2Canada Awards C$1.5 Billion Defense Contracts to L3Harris, Airbus
- 310 Famous Frozen yogurt Flavors All over The Planet
- 4the Wild in Style: The Reduced Portage Mustang's Bold Heritage
- 5Shas threatens to oppose 2026 state budget over haredi food-voucher exclusion
- Brazil judge orders government to add JBS subsidiary to 'dirty list' for slavery
- Idris Elba is the king of the stress-watch
- Avoid Slam: Exploring the Pickup Truck Transformation
- Nestlé says 413,793 KitKat candy bars stolen en route from Italy to Poland
- 6 Modest and Strong Tire Brands
- Our favorite Space.com stories of 2025
- Winona Ryder didn't take the 'Stranger Things' plot lightly. How 'otherworldly' grief and a kidnapping in her hometown informed her character.
- What Yogurt Types Do You Know
- Book excerpt: "Eat Your Ice Cream" by Ezekiel J. Emanuel, M.D.
